Efficacy of Complete Mesocolic Excision Combined with Ulinastatin in Treatment of Right-Side Colon Carcinoma and its Effects on Serum Midkine and Tumor Specific Growth Factor

CHEN Minggan; DING Xinde; ZHANG Bo; ZHU Songming

doi:10.14009/j.issn.1672-2124.2020.04.017

您当前的位置：

首页 >

文章列表页 >

Efficacy of Complete Mesocolic Excision Combined with Ulinastatin in Treatment of Right-Side Colon Carcinoma and its Effects on Serum Midkine and Tumor Specific Growth Factor

更新时间：2022-10-08

- Efficacy of Complete Mesocolic Excision Combined with Ulinastatin in Treatment of Right-Side Colon Carcinoma and its Effects on Serum Midkine and Tumor Specific Growth Factor
- Vol. 20, Issue 4, Pages: 446-449(2020)
- 作者机构：
  
  上海交通大学医学院附属新华医院崇明分院普外科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.04.017
  CLC： R735.35
- Published：2020，
扫描看全文
[1]陈明干,丁新德,章波,朱松明.全结肠系膜切除术联合术后乌司他丁治疗右半结肠癌的效果及对血清中期因子、肿瘤特异性生长因子水平的影响[J].中国医院用药评价与分析,2020,20(04):446-449+452.

CHEN Minggan, DING Xinde, ZHANG Bo, et al. Efficacy of Complete Mesocolic Excision Combined with Ulinastatin in Treatment of Right-Side Colon Carcinoma and its Effects on Serum Midkine and Tumor Specific Growth Factor. [J]. 20(4):446-449(2020)
[1]陈明干,丁新德,章波,朱松明.全结肠系膜切除术联合术后乌司他丁治疗右半结肠癌的效果及对血清中期因子、肿瘤特异性生长因子水平的影响[J].中国医院用药评价与分析,2020,20(04):446-449+452. DOI： 10.14009/j.issn.1672-2124.2020.04.017.

CHEN Minggan, DING Xinde, ZHANG Bo, et al. Efficacy of Complete Mesocolic Excision Combined with Ulinastatin in Treatment of Right-Side Colon Carcinoma and its Effects on Serum Midkine and Tumor Specific Growth Factor. [J]. 20(4):446-449(2020) DOI： 10.14009/j.issn.1672-2124.2020.04.017.

摘要

目的:探讨全结肠系膜切除术联合术后乌司他丁治疗右半结肠癌的效果及对血清中期因子（MK）、肿瘤特异性生长因子（TSGF）水平的影响。方法:选取2015年2月至2018年2月上海交通大学医学院附属新华医院崇明分院收治的右半结肠癌根治术患者120例作为研究对象

按照匹配原则分为对照组和研究组

每组60例。两组患者均进行全结肠系膜切除术

在此基础上

研究组患者术后给予乌司他丁静脉滴注治疗。观察两组患者的治疗效果

治疗前后主要肝肾功能指标[丙氨酸氨基转移酶（ALT）、天门冬氨酸氨基转移酶（AST）、总胆红素（TBIL）、肌酐及尿素氮（BUN）]、MK、TSGF、炎症因子[肿瘤坏死因子α（TNF-α）、白细胞介素6（IL-6）及白细胞介素8（IL-8）]

及免疫功能指标水平和主要并发症发生情况。结果:研究组患者术后进食流质时间、恢复正常饮食时间和住院时间明显短于对照组

差异均有统计学意义（P

0.05）。术后1、3 d

两组患者ALT、AST、TBIL、肌酐和BUN水平均较治疗前明显升高

但研究组患者明显低于对照组

差异均有统计学意义（P

0.05）。治疗后

两组患者血清MK、TSGF、TNF-α、IL-6、IL-8、CD4

及CD8

水平较治疗前明显降低

且研究组患者明显低于对照组

差异均有统计学意义（P

0.05）。研究组、对照组患者的并发症发生率分别为26.67%（16/60）、21.67%（13/60）

差异无统计学意义（P

0.05）。结论:全结肠系膜切除术联合术后乌司他丁治疗右半结肠癌的疗效显著

能明显缩短患者的住院时间

改善患者预后

且对术后患者肝肾功能具有一定的保护作用

可显著降低肿瘤相关标志物水平

同时安全性较高。

Abstract

OBJECTIVE:To probe into the efficacy of complete mesocolic excision（CME）combined with ulinastatin in treatment of right-side colon carcinoma and its effects on serum midkine（MK）and tumor specific growth factor（TSGF）.METHODS:120 patients with right-side colon carcinoma admitted into Chongming Hospital of Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine from Feb.2015 to Feb.2018 were selected and divided into control group and research group according to the matching principle

with 60 cases in each group.Both groups were treated with CME

on this basis

the research group was given ulinastatin for intravenous drip after surgery.The clinical efficacy

primary hepatic and renal indices[alanine aminotransferase（ALT）

aspartate aminotransferase（AST）

total bilirubin（TBIL）

creatinine and blood urea nitrogen（BUN）]

TSGF

inflammatory factors[tumor necrosis factor-α（TNF-α）

interleukin-6（IL-6）and interleukin-8（IL-8）]

immunological function indices and incidences of main complications of both groups were observed.RESULTS:The postoperative food-taking time

recovery time of normal diet and hospital stay of research group were significantly shorter than those of the control group

with statistically significant differences（P

0.05）.At 1 day and 3 days after surgery

the ALT

AST

TBIL

creatinine and BUN levels of both groups had been significantly increased

and those of research group were significantly lower than the control group

with statistically significant differences（P

0.05）.After treatment

the serum MK

TSGF

TNF-α

IL-6

IL-8

CD4

and CD8

levels of both groups had been significantly decreased

and those of research group were significantly lower than the control group

with statistically significant differences（P

0.05）.The incidences of complication of research group and control group were respectively 26.67%（16/60）and 21.67%（13/60）

the difference had no statistical significance（P

0.05）.CONCLUSIONS:The efficacy of CME combined with ulinastatin in treatment of right-side colon carcinoma is remarkable

which can significantly shorten hospital stay and improve patients’prognoses

which has protection for patients’hepatic and renal function

and effectively reduce tumor related marker levels with higher safety.

关键词

全结肠系膜切除术乌司他丁右半结肠癌中期因子肿瘤特异性生长因子

Keywords

Complete mesocolic excisionUlinastatinRight-side colon cancerMidkineTumor-specific growth factor

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy and Prognosis of Ulinastatin Combined with Alprostadil in the Adjuvant Treatment of Acute Respiratory Distress Syndrome Induced by Sepsis

Efficacy of Ulinastatin Combined with Imipenem in the Treatment of Acute Respiratory Distress Syndrome Induced by Sepsis and its Effect on Leukocyte-Platelet Aggregate Level and Cardiac Function

Analysis on the Protective Mechanism of Ulinastatin on Early Radiation-Induced Pulmonary Injury Based on the Signal Pathway of High Mobility Group Box-1 Protein

Related Author

XIANG Hai

LIU Cuihua

YANG Yun

LIN Sen

DENG Wuxing

GUAN Wantao

GONG Baoqiang

YANG Jun

Related Institution

Dept.of Respiratory and Critical Care,Mianyang Central Hospital

Dept.of Emergency,Mianyang Central Hospital

Dept.of Intensive Care Unit,the Third People’s Hospital of Hainan

Dept.of Respiratory Medicine,People’s Hospital of Wuhan University

Dept.of Respiratory Medicine,Qingpu Hospital of Zhongshan Hospital Affiliated to Fudan University

⁰